Acute-onset severe gastrointestinal tract hemorrhage in a postoperative patient taking rivaroxaban after total hip arthroplasty: a case report

INTRODUCTION: Rivaroxaban, a new oral anticoagulant, is currently licensed for use in patients undergoing orthopedic surgery. It is more efficacious than other anticoagulants such as low molecular weight heparin and does not require daily monitoring. It has also been shown to be efficacious in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Boland, Michael, Murphy, Maria, Murphy, Marese, McDermott, Enda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407781/
https://www.ncbi.nlm.nih.gov/pubmed/22584072
http://dx.doi.org/10.1186/1752-1947-6-129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407781/
https://www.ncbi.nlm.nih.gov/pubmed/22584072
http://dx.doi.org/10.1186/1752-1947-6-129

Ejemplares similares